1. Home
  2. IPHA vs TRAK Comparison

IPHA vs TRAK Comparison

Compare IPHA & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.61

Market Cap

165.3M

Sector

Health Care

ML Signal

N/A

TRAK

ReposiTrak Inc.

SELL

Current Price

$7.97

Market Cap

157.2M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
IPHA
TRAK
Founded
1999
1990
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
165.3M
157.2M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
IPHA
TRAK
Price
$1.61
$7.97
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $6.67
N/A
AVG Volume (30 Days)
47.7K
★ 82.8K
Earning Date
09-17-2026
09-28-2026
Dividend Yield
N/A
★ 0.99%
EPS Growth
N/A
★ 11.43
EPS
N/A
★ 0.39
Revenue
N/A
★ $21,007,076.00
Revenue This Year
$390.56
$9.50
Revenue Next Year
$143.06
$10.00
P/E Ratio
★ N/A
$20.72
Revenue Growth
N/A
★ 4.84
52 Week Low
$1.18
$6.94
52 Week High
$2.71
$15.80

Technical Indicators

Market Signals
Indicator
IPHA
TRAK
Relative Strength Index (RSI) 33.42 42.22
Support Level $1.34 $7.45
Resistance Level $1.87 $9.06
Average True Range (ATR) 0.12 0.28
MACD -0.02 -0.01
Stochastic Oscillator 11.19 31.35

Price Performance

Historical Comparison
IPHA
TRAK

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

Share on Social Networks: